Ask Lazlo

life sciences… only

Whole Genome Sequencing

The standard approach in clinical DNA sequencing is that you focus on the most high impact stretches of DNA only, thereby reducing the number of base pairs that need to be sequenced.  Nonetheless, a new report to be released in todays journal Nature, discusses the whole genome sequencing of a cancer patient.

The project studied the genome of a tumor cell in a woman with acute myelogenous leukemia (AML) and compared the sequence to the genome of the same woman’s healthy skin cells.  According to the researchers, eight new mutations were identified that were specific to the patients cancer cells.

This study should invigorate the discussion surrounding whole genome sequencing and justify researchers looking to genotype entire genomes.

Advertisements

November 6, 2008 - Posted by | Biotech | , , ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: